STAMFORD, Conn., June 4, 2026 /PRNewswire/ -- Hedgeye Asset Management, a provider of actively managed exchange-traded funds built on Hedgeye's proprietary research, macro process and...
WESTERN SHORE, NS, June 4, 2026 /CNW/ - As Canada's labour market continues to face sustained pressures from tariffs, skills shortages, supply chain disruptions,...
Seven Chef-Inspired Sauces Deliver Approximately Half the Sugar and Calories of Leading Brands While Elevating Everyday Grilling and CookingDELRAY BEACH, Fla., June 4, 2026...
TAIPEI, June 4, 2026 /PRNewswire/ -- Compal Electronics (Compal; TWSE: 2324) showcases its landmark achievements in Quantum Technology and Advanced Artificial Intelligence (AI) at COMPUTEX...
ARLINGTON, TX, June 03, 2026 (GLOBE NEWSWIRE) -- Greenway Technologies, Inc. (OTCQB: GWTI) (“Greenway”), an advanced gas-to-liquids (“GTL”) and gas-to-hydrogen (“GTH”) technology development company, announced that on May 28, 2026, Raymond Wright notified the Board of Directors (the “Board”) of Greenway of his resignation from his positions as a Board member and as Interim President of Greenway, effective on such date. In connection with his transition, the Board unanimously approved the conferral of the honorary title Chairman Emeritus in recognition of Mr. Wright’s long-standing leadership and foundational contributions to Greenway. The role of Chairman Emeritus is not a Board position and does not carry a vote.
New York, NY, June 03, 2026 (GLOBE NEWSWIRE) -- Bayview Acquisition Corp (NASDAQ: BAYA, BAYAU, and BAYAR) (the “Company”) announced that, at its extraordinary general meeting of shareholders held on May 28, 2026 (the “Meeting”), its shareholders approved the proposals to extend the deadline by which the Company must complete its initial business combination, and that redemptions in connection with the vote were limited.
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.
RENO, Nevada, June 03, 2026 (GLOBE NEWSWIRE) -- Globaltech Corporation (“Globaltech” or the “Company”) (OTCQB: GLTK), a U.S.-based technology holding company, is providing this Update to Shareholders to discuss: (i) how we are managing and operating the Company day to day, (ii) our near-term priorities with a long-term orientation, and (iii) how we responsibly and methodically approach innovation, including AI-enabled products and services.
New collaboration delivers a fully integrated formulation workflow from early solubility studies to high-throughput dissolution, stability, and in-process analytics, making drug formulation less artisanal...
VALENCIA, Calif., June 3, 2026 /PRNewswire/ -- Sunkist Growers unveiled a refreshed Sunkist.com experience, introducing a bold new digital platform built around a simple...
The fundraiser included a Series A investment led by Khosla Ventures and strategic investment from BHP VenturesPALO ALTO, Calif., June 3, 2026 /PRNewswire/ -- Terra...
The fundraiser included a Series A investment led by Khosla Ventures and strategic investment from BHP VenturesPALO ALTO, Calif., June 3, 2026 /PRNewswire/ -- Terra...